MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/08880018.2021.2005725

Медицинская библиотека · Pediatric hematology and oncology · 2022

Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India.

Vijayasekharan Kalasekhar, Kc Anand, Prasad Maya, Dhamne Chetan, Roy Moulik Nirmalya, Shet Tanuja, Sridhar Epari, Laskar Siddhartha, Kembhavi Seema, Shah Sneha, Gujral Sumeet, Narula Gaurav, Banavali Shripad D

СтатьяПеревод пока не подготовлен

Аннотация

Pediatric B-cell lymphoblastic lymphoma (LBL) is a rare entity, and appropriate treatment for pediatric B-cell LBL is not well defined. While intensive ALL type regimens achieve long term survival of 90% across Western co-operative group trials, published data from Asian studies on long term outcomes are scarce. We retrospectively analyzed the data of pediatric B-cell LBL patients treated between January 2010 and December 2017 on a uniform protocol (modified BFM 90). Kaplan-Meier method was used to estimate the survival and Cox regression models to identify prognostic factors. Of 21 patients who received treatment on the modified BFM-90 protocol, 17(81%) were alive in remission, 3(14%) had relapse, and 1(4%) had treatment-related mortality (TRM) while in remission. Two of 3 relapsed patients subsequently expired. With a median follow-up of 66 months (range 6-114), 5-year event free survival (EFS) and overall survival (OS) were 80% (95% CI:71-89%) and 91% (95% CI:85-97%), respectively. While delayed presentation from symptom onset (p=0.030), and partial response at early (D35) interim assessment (p=0.025) had inferior EFS, patients with elevated baseline LDH had a worse OS (p=0.037). Outcomes of pediatric B-cell LBL patients treated on a modified BFM-90 protocol at a single center in India were excellent. In our study, higher disease burden manifested by elevated baseline LDH and delayed presentation (≥3months) and partial interim response portend poorer survival.Supplemental data for this article is available online at https://doi.org/10.1080/08880018.2021.2005725.

Для цитирования: Vijayasekharan Kalasekhar, Kc Anand, Prasad Maya, Dhamne Chetan, Roy Moulik Nirmalya, Shet Tanuja, Sridhar Epari, Laskar Siddhartha, Kembhavi Seema, Shah Sneha, Gujral Sumeet, Narula Gaurav, Banavali Shripad D. Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India.. Pediatric hematology and oncology. 2022. DOI: 10.1080/08880018.2021.2005725.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.